Physician

Renee Powell Warford, M.D.

According to 2025 Medicare claims, Renee Warford, M.D. (NPI: 1730575432) practices urology in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 71913-6457. Warford is affiliated with the Baptist Health/UAMS Accountable Care Alliance (ACO ID: A3633) and AdvantagePoint Health Alliance - Hot Springs, LLC (ACO ID: A5037), participating under the MSSP model.

Warford's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 701 traditional Medicare patients, billed 8,530 HCPCS/CPT codes, and received $233,897 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,799 prescription claims across 632 beneficiaries totaling $236,508 in drug costs, led by Gemtesa (Vibegron). DME data shows 20 claims. Open Payments data shows 26 records totaling $980. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $61,469 and ending at $233,897. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,629 to $236,508. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	203	1,855	$61,469
2021	491	5,623	$189,889
2022	524	6,585	$215,074
2023	563	6,229	$162,194
2024	701	8,530	$233,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	15	36	$6,629
2016	64	156	$4,269
2017	81	172	$3,202
2018	41	63	$839
2019	17	25	$150
2020	100	217	$12,067
2021	271	882	$60,114
2022	333	1,056	$81,027
2023	387	1,126	$97,684
2024	632	1,799	$236,508

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	20	$7,454

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	165	197	$149
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	173	173	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	336	510	$81
51798	Ultrasound measurement of bladder capacity after voiding	359	476	$6
81002	Urinalysis, manual test	460	681	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	107	4,009	$62,652
Orgovyx	Relugolix	20	596	$54,185
Myrbetriq	Mirabegron	41	1,766	$26,573
Estradiol	Estradiol	282	23,138	$16,760
Tamsulosin Hcl	Tamsulosin Hcl	368	21,777	$3,516

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	20	$7,454

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$980	COLOPLAST CORP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Renee Powell Warford, M.D.?

Tedicare shows public-source Medicare data for Renee Powell Warford, M.D. (NPI 1730575432), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renee Powell Warford, M.D. have ACO affiliation data?

Renee Powell Warford, M.D. is shown with ACO affiliation data for Baptist Health/UAMS Accountable Care Alliance (MSSP, ACO ID A3633) and AdvantagePoint Health Alliance - Hot Springs, LLC (MSSP, ACO ID A5037).

What billing organization is linked to Renee Powell Warford, M.D.?

Renee Powell Warford, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Renee Powell Warford, M.D. have Open Payments data?

Renee Powell Warford, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.